| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 97 | 142 | 1,238 | 353 | | Cost of Revenue | 13 | 5 | 914 | 213 | | | Gross Profit | 84 | 137 | 324 | 140 | | | Operating Expenses | | Research Development | 938 | 763 | 642 | 609 | | Selling General and Administrative | 1,120 | 16,106 | 903 | 922 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 93 | 79 | 40 | 42 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,067) | (16,811) | (1,261) | (1,433) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 132 | 284 | 4,281 | (3,202) | | Earnings Before Interest And Taxes | (4,853) | (16,527) | 3,020 | (4,635) | | Interest Expense | (2,917) | 2,276 | 755 | 646 | | Income Before Tax | (1,936) | (18,803) | 2,265 | (5,281) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,936) | (18,803) | 2,265 | (5,281) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,936) | (18,803) | 2,265 | (5,281) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,936) | ($18,803) | $2,265 | ($5,281) |
|
0.51% Nasdaq 
Income Statement
